For this presentation we welcome Unicycive Therapeutics. Unicycive Therapeutics (Nasdaq: UNCY) is a biotechnology company developing novel treatments for kidney diseases.

This fireside chat was recorded during the Lytham Partners Spring 2025 Investor Conference.